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Background: The ultimate treatment goal in acute myocardial infarction is rapid restoration of coronary blood flow. In general, fibrinolysis can be 
initiated earlier than primary percutaneous intervention (PPCI); however, fibrinolysis lacks the efficacy and durability of PPCI. Multiple combinations 
of fibrinolysis and mechanical reperfusion have been previously evaluated; however, results of these trials have been mixed.
Methods: We treated 903 STEMI patients between March 2005 and June 2009. One-third of these patients were treated with pre-hospital 
fibrinolytics followed by urgent PCI. Many patients also underwent delayed enhancement cardiac MRI. Using previously described methods, we 
measured microvascular obstruction (MVO) and infarct size in 300 patients.
Results: Complete imaging and clinical data was available for 124 patients. Groups were well matched for age, cardiac risk factors and ischemic 
time. STEMI patients receiving pre-hospital fibrinolytics demonstrated smaller infarcts on MRI. Pre-hospital treated patients also developed less 
microvascular obstruction. Mean change in hemoglobin was similar, and there were no life threatening bleeding events. 
Pre-Hospital Fibrinolysis + PCI
(N=75)
Primary PCI
(N=49)
P-Value
Age (yrs) 58.7 +/-11.5 57.3 +/-10.6 0.886
Scar Volume (cm3) 14.9 +/-16.3 21.5 +/-17.7 0.055
Scar Volume
(% myocardial mass)
9.5 +/-7.0 12.7 +/-9.0 0.038
MVO (cm3) 1.41 +/-2.97 3.22 +/-5.36 0.001
MVO (% scar volume) 5.4 +/-6.0 9.2 +/-10.0 0.001
Avg. Hb Loss (gm) 2.4 +/-1.5 2.0 +/-1.4 0.328
Conclusions: In STEMI patients presenting early after symptom onset, pre-hospital reduced-dose fibrinolytic therapy leads to smaller infarcts and 
less microvascular obstruction without increased bleeding risk compared to primary PCI.
